الصفحة الرئيسية>>Natural Products>>Laminaran

Laminaran

رقم الكتالوجGC39259

Laminaran هو β ؛ -1-3-glucan و ligand نموذجي لـ Dectin-1 من Eisenia Bicyclis ، له أنشطة مناعية قوية ومضادة للأشعة ومضادة للسرطان. يتكون Laminaran من β ؛ (1→؛ 3) -جلوكان مع β ؛ (1→؛ 6) - الفروع ويمكن تحفيزها بواسطة إنزيمات مثل أميناريناز (EC 3.2.1.6) التي تكسر β ؛ (1→؛ 3) السندات. Laminaran هو جزيء محفز مناعي واعد يستخدم في العلاج المناعي للسرطان.

Products are for research use only. Not for human use. We do not sell to patients.

Laminaran التركيب الكيميائي

Cas No.: 9008-22-4

الحجم السعر المخزون الكميّة
100mg
35٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Chemical Properties Product Documents Related Products

Laminaran is a neutral water-soluble β-1-3-glucan and a typical ligand for Dectin-1 isolated from the brown alga D. dichotoma, has potent immunomodulating, radioprotective, and anticancer activities[1]. Laminaran is made up of β (1→3)-glucan with β (1→6)-branches and can be catalyzed by enzymes such as laminarinase (EC 3.2.1.6) that breaks the β (1→3) bonds[2]. Laminaran is a promising immune stimulatory molecule for use in cancer immunotherapy[3].

[1]. Malyarenko OS, et al. Laminaran from brown alga Dictyota dichotoma and its sulfated derivative as radioprotectors and radiosensitizers in melanoma therapy.Carbohydr Polym. 2019 Feb 15;206:539-547. [2]. Laminaran [3]. Song K, et al. Laminarin promotes anti-cancer immunity by the maturation of dendritic cells.Oncotarget. 2017 Jun 13;8(24):38554-38567.

مراجعات

Review for Laminaran

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Laminaran

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.